ADMI
MYGN icon

Albert D. Mason Inc’s Myriad Genetics MYGN Stock Holding History

Albert D. Mason Inc’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-6,440
Closed -$296K – 138
2018
Q3 		$296K Sell
6,440
-1,430
-18% -$63.6K 0.2% 120
2018
Q2 		$294K Sell
7,870
-8,292
-51% -$280K 0.21% 120
2018
Q1 		$478K Sell
16,162
-270
-2% -$9.14K 0.36% 103
2017
Q4 		$564K Buy
16,432
+110
+0.7% +$3.71K 0.42% 93
2017
Q3 		$591K Sell
16,322
-60
-0.4% -$1.71K 0.48% 89
2017
Q2 		$423K Hold
16,382
– – 0.35% 96
2017
Q1 		$315K Buy
16,382
+250
+2% +$4.43K 0.27% 100
2016
Q4 		$269K Sell
16,132
-27,792
-63% -$503K 0.23% 101
2016
Q3 		$904K Buy
43,924
+19,492
+80% +$494K 0.29% 102
2016
Q2 		$748K Buy
24,432
+123
+0.5% +$4.27K 0.43% 85
2016
Q1 		$910K Hold
24,309
– – 0.56% 73
2015
Q4 		$1.05M Sell
24,309
-822
-3% -$34.7K 0.68% 61
2015
Q3 		$942K Sell
25,131
-598
-2% -$21.2K 0.58% 72
2015
Q2 		$875K Sell
25,729
-122,703
-83% -$4.17M 0.47% 78
2015
Q1 		$5.25M Buy
148,432
+103,042
+227% +$3.69M 1.09% 32
2014
Q4 		$1.55M Buy
45,390
+18,790
+71% +$667K 0.31% 101
2014
Q3 		$1.03M Buy
+26,600
New +$993K 0.2% 112

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Albert D. Mason Inc's MYGN Position: Q4 2018 in Review

Albert D. Mason Inc sold out of Myriad Genetics (MYGN) in Q4 2018, closing a stake of 6,440 shares — an estimated $296K sold.

Albert D. Mason Inc first reported a position in MYGN in Q3 2014 and held it in 17 quarters. The position peaked at $5.25M in Q1 2015. 264 funds tracked by Wall St. Rank hold MYGN as of Q4 2018.

  • Albert D. Mason Inc reported no remaining Myriad Genetics position as of Q4 2018 after selling out during the quarter.
  • Albert D. Mason Inc sold 6,440 Myriad Genetics shares in Q4 2018, an estimated $296K.
  • Albert D. Mason Inc first reported a position in Myriad Genetics in Q3 2014 and held it in 17 quarters.
  • Albert D. Mason Inc's Myriad Genetics position peaked at $5.25M in Q1 2015.
  • 264 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2018.

Based on Albert D. Mason Inc's 13F filing for Q4 2018, filed 29 Jan 2019.